Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Angioimmunoblastic T-cell lymphoma (AITL) is the second most common subtype of peripheral T-cell lymphoma, accounting for approximately 15–20% of the cases [1]. It is a systemic lymphoproliferative disorder that typically presents with constitutional symptoms, generalized lymphadenopathy, hepatosplenomegaly, skin rash, and immunological disturbances [2]. AITL may be accompanied by either polyclonal or clonal proliferation of B lymphocytes, which seems to be triggered by Epstein-Barr virus (EBV) infection [3].
Abstract
Angioimmunoblastic T-cell lymphoma (AITL) is the second most common subtype of peripheral T-cell lymphoma, accounting for approximately 15–20% of the cases [1]. It is a systemic lymphoproliferative disorder that typically presents with constitutional symptoms, generalized lymphadenopathy, hepatosplenomegaly, skin rash, and immunological disturbances [2]. AITL may be accompanied by either polyclonal or clonal proliferation of B lymphocytes, which seems to be triggered by Epstein-Barr virus (EBV) infection [3].
참고문헌 (10)
- Swerdlow S, "WHO classification of tumours of haematopoietic and lymphoid tissues", International Agency for Research on Cancer, 309~311 (2008)
- Hawley RC, "Angioimmunoblastic T-cell lymphoma with supervening Epstein-barr virus-associated large B-cell lymphoma", Arch Pathol Lab Med, 130, pp.1707~1711 (2006)
- Xu J, "Angioimmunoblastic T-cell lymphoma with coexisting plasma cell myeloma: a case report and review of the literature", Tohoku J Exp Med, 235, pp.283~288 (2015)[DOI]
- Foucar K, "Bone marrow pathology", pp.557~577 (2010), American Society for Clinical Pathology
- Grogg KL, "Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma", Br J Haematol, 137, pp.416~422 (2007)[DOI]
- Zettl A, "Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified", Am J Clin Pathol, 117, pp.368~379 (2002)[DOI]
- 최윤희, "혈관면역 T세포 림프종 치료 후 발생한 엡스타인바 바이러스 양성 미만성 큰 B세포 림프종 1예", Blood Research, 43(3), pp.174~178 (2008), 대한혈액학회
- Zhou Y, "Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma", J Hematop, 8, pp.235~241 (2015)[DOI]
- Kasahara H, "Successful treatment with rituximab for angioimmunoblastic T-cell lymphoma", Leuk Res Rep, 2, pp.36~38 (2013)
- Delfau-Larue MH, "Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA", Haematologica, 97, pp.1594~1602 (2012)[DOI]